USD605753S1 - Cartridge for a dry powder inhaler - Google Patents

Cartridge for a dry powder inhaler Download PDF

Info

Publication number
USD605753S1
USD605753S1 US29/319,776 US31977608F USD605753S US D605753 S1 USD605753 S1 US D605753S1 US 31977608 F US31977608 F US 31977608F US D605753 S USD605753 S US D605753S
Authority
US
United States
Prior art keywords
cartridge
dry powder
powder inhaler
shown
view
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/319,776
Inventor
Chad C. Smutney
P. Spencer Kinsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mannkind Corp
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Priority to US29/319,776 priority Critical patent/USD605753S1/en
Assigned to MANNKIND CORPORATION reassignment MANNKIND CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KINSEY, P. SPENCER, SMUTNEY, CHAD C.
Priority claimed from US29/333,230 external-priority patent/USD613849S1/en
Application granted granted Critical
Publication of USD605753S1 publication Critical patent/USD605753S1/en
Assigned to DEERFIELD PRIVATE DESIGN FUND II, L.P., DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P., HORIZON SANTE FLML SARL reassignment DEERFIELD PRIVATE DESIGN FUND II, L.P. SECURITY AGREEMENT Assignors: MANNKIND CORPORATION
Assigned to AVENTISUB LLC reassignment AVENTISUB LLC PATENT SECURITY AGREEMENT Assignors: MANNKIND CORPORATION
Assigned to MANNKIND CORPORATION reassignment MANNKIND CORPORATION RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: AVENTISUB LLC
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a side and top perspective view of our new cartridge design in a containment configuration..

FIG. 2 is a side and top perspective view of the cartridge in a dosing configuration.

FIG. 3 is a side view of the cartridge as shown in FIG. 1.

FIG. 4 is a back view of the cartridge as shown in FIG. 1.

FIG. 5 is a front view of the cartridge as shown in FIG. 2.

FIG. 6 is a top view of the cartridge as shown in FIG. 1; and,

FIG. 7 is a bottom view of the cartridge of FIG. 1.

Claims (1)

  1. The ornamental design for a cartridge for a dry powder inhaler, as shown and described.
US29/319,776 2008-06-13 2008-06-13 Cartridge for a dry powder inhaler Active USD605753S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/319,776 USD605753S1 (en) 2008-06-13 2008-06-13 Cartridge for a dry powder inhaler

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29/319,776 USD605753S1 (en) 2008-06-13 2008-06-13 Cartridge for a dry powder inhaler
CA 128912 CA128912S (en) 2008-06-13 2008-12-10 Cartridge for a dry powder inhaler
US29/333,230 USD613849S1 (en) 2008-06-13 2009-03-04 Cartridge for a dry powder inhaler
US29/356,555 USD664640S1 (en) 2008-06-13 2010-02-26 Cartridge for a dry powder inhaler

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US29/333,230 Continuation-In-Part USD613849S1 (en) 2008-06-13 2009-03-04 Cartridge for a dry powder inhaler

Publications (1)

Publication Number Publication Date
USD605753S1 true USD605753S1 (en) 2009-12-08

Family

ID=41394775

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/319,776 Active USD605753S1 (en) 2008-06-13 2008-06-13 Cartridge for a dry powder inhaler

Country Status (2)

Country Link
US (1) USD605753S1 (en)
CA (1) CA128912S (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin

Also Published As

Publication number Publication date
CA128912S (en) 2009-11-16

Similar Documents

Publication Publication Date Title
USD643433S1 (en) Sleeve for tablet PC
USD606539S1 (en) Pocket pc
USD628535S1 (en) Portable charger
USD649144S1 (en) Case
USD573026S1 (en) Container for cosmetics
USD585657S1 (en) Chair
USD646923S1 (en) Container cover
USD637484S1 (en) Beverage cartridge
USD667674S1 (en) Liquid dispenser and filter
USD647398S1 (en) Beverage cartridge
USD579548S1 (en) Inhaler
USD647399S1 (en) Beverage cartridge
USD597418S1 (en) Blister card
USD631708S1 (en) Container and lid
USD650280S1 (en) Container
USD567107S1 (en) Combined container and pump
USD601425S1 (en) Container
USD581787S1 (en) Dispensing device
USD582544S1 (en) Metered dose inhaler
USD634127S1 (en) Cosmetic brush
CA128914S (en) Dry powder inhaler
USD648535S1 (en) Container
USD629887S1 (en) Dry powder inhaler
USD659004S1 (en) Cosmetic jar with cover
USD604164S1 (en) Container